Quick Answer
Acurx Pharmaceuticals, Inc. reported Total Assets of $7.69 million for fiscal year 2025.
Acurx Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.69M | +99.3% |
| 2024 | $3.86M | -50.0% |
| 2023 | $7.71M | -17.8% |
| 2022 | $9.38M | -29.3% |
| 2021 | $13.25M | +311.1% |
| 2020 | $3.22M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.11M | — | +58.2% |
| December 31, 2024 | $3.86M | -50.0% | -41.4% |
| June 30, 2024 | $6.58M | — | -27.8% |
| March 31, 2024 | $9.11M | — | +18.2% |
| December 31, 2023 | $7.71M | — | -16.7% |
| June 30, 2022 | $9.26M | -46.9% | -18.2% |
| March 31, 2022 | $11.32M | — | -14.6% |
| December 31, 2021 | $13.25M | +311.1% | -11.6% |
- Acurx Pharmaceuticals, Inc. showed an increase of +99.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Acurx Pharmaceuticals, Inc.’s total assets has grown by 138.5% (from $3.22 million to $7.69 million).
- The most recent figure is from Acurx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: